Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Akorn, Inc.

Akorn Sharpens Focus As It Divests Ophthalmic Brands

Akorn says it is concentrating its focus on “targeted avenues of growth” – including human generics and animal care – after divesting its branded ophthalmic portfolio to Théa Pharma.

Deals Strategy

China Aims To Be Robotics Industry’s Global Innovation Center

China has released a five-year plan for the development of the robotics industry. Health care applications are a key part of that plan, according to reports from Omdia.

China Digital Health

US Q4 Consumer Health Earnings Preview: Inflation Impact Follows Pandemic-Driven Disruption

Cost increases initially spurred by supply chain disruptions by COVID-19 pandemic have been noted by businesses across consumer product industries since soon after novel coronavirus spread accelerated in early 2020.  More recently, OTC drug, nutritional supplement and personal care product providers began noting inflation’s influence on costs.

Pricing Strategies Coronavirus COVID-19

‘Bugs As Drugs’ Approach To Cancer Nears Advanced Development

Microbiome modulators, known mainly for development in infectious and gastrointestinal diseases, could prove an asset in oncology thanks to the work of biotechs.

ImmunoOncology Companies
See All

Company Information

  • Industry
  • Distributors
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Hi-Tech Pharmacal
    • Oak Pharmaceuticals, Inc., VersaPharm
UsernamePublicRestriction

Register